ArticleBMC infectious diseases2025
Cross-sectional study on the seroprevalence, reinfection, and associated factors of Chlamydia trachomatis among female sex workers in Guangdong Province, China.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundFemale sex workers (FSWs) are at high risk of chlamydia infection, yet the seroprevalence among FSWs in China remains unclear. This study aimed to determine the seroprevalence of Chlamydia trachomatis and associated factors among FSWs in Guangdong Province, China.
methodsA cross-sectional study was conducted among FSWs in two cities in Guangdong Province. Participants provided serum and urine samples. Nucleic acid amplification test (NAAT) was used to detect Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) in urine samples. Enzyme-linked immunosorbent assay (ELISA) was used to detect chlamydia IgG antibodies in serum samples. Seropositivity was defined by IgG-positive results. Current chlamydia infection was identified by a positive NAAT result, while prior infection was indicated by positive chlamydia IgG and negative NAAT results. Reinfection was defined by positive results for both NAAT and chlamydia IgG. Moreover, positive ELISA results were reclassified into two categories: DU/mL values ≥ 37.89 (the median) were classified as high-positive and DU/mL values > 11 to 37.89 as low-positive. Sociodemographic data, CT and NG testing, and paper questionnaires were collected through face-to-face interviews. Univariate and multivariable logistic regressions explored factors associated with current CT infection.
resultsA total of 435 serum and urine samples were analyzed. The median age of the participants was 32.0 (IQR: 27.0-37.0) years. Among the participants, 326 were CT IgG positive, resulting in an overall seroprevalence of 74.9% (95% CI, 70.6-78.9). The current infection proportion determined by NAAT was 12.2% (53/435) (95% CI, 9.3-15.6), significantly lower than the IgG seroprevalence. Seroprevalence was higher among those over 39 years (88.6%) compared to those under 20 years (62.5%). High seroprevalence was observed among NAAT-negative participants (74.3%, 95% CI, 69.7-78.7). Single, divorced, or widowed individuals had higher seroprevalence (78.4%, 95% CI, 72.9-83.1) compared to married ones (69.5%, 95% CI, 61.9-76.3) (P < 0.05). Among seropositive participants, 42 were both NAAT and chlamydia IgG positive, indicating a reinfection proportion of 12.9% (95% CI, 9.4-17.0). Among reinfections, 81.0% had high seropositivity and 19.0% had low seropositivity. Reinfection prevalence was highest in those under 20 years (50%, 95% CI, 18.7-81.3) (P < 0.05).
conclusionThis study found a high prevalence of anti-chlamydia IgG among FSWs, including those who were NAAT-negative. Additionally, there was a high reinfection proportion among Chinese FSWs. CT serological assays are increasingly recognized as valuable epidemiological tools. Younger FSWs and those new to transactional sex may be at higher risk and should be prioritized for community-based prevention interventions to reduce the burden of CT transmission. Overall, CT serological assays are increasingly recognized as valuable tools for epidemiological surveillance and intervention. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.